Form 4: Hims & Hers CCO Exercises, Sells Shares

Hims & Hers Health, Inc.'s Chief Commercial Officer, Michael Chi, executed a pre-planned exercise of stock options and subsequent sale of 900 Class A Common Stock shares.

Summary

• Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., reported an insider transaction on October 10, 2025.
• The transaction involved the exercise of 900 stock options at a price of $6.82 per share.
• Immediately following the exercise, 900 shares of Class A Common Stock were sold at a price of $58.25 per share.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Chi on March 4, 2025.
• Following these transactions, Mr. Chi beneficially owns 291,439 shares of Class A Common Stock and 115,362 stock options.
• The stock options are subject to a service-based vesting requirement over a 4-year period, with 1/48th vesting monthly after September 10, 2022.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider transaction (exercise and sale of options) which is generally considered neutral for the company's overall sentiment. The officer realized a profit, which is positive for the individual, but the transaction itself does not indicate a change in company fundamentals.

Positives

• The Chief Commercial Officer realized a significant profit from the option exercise and sale, with shares sold at $58.25 after being acquired at an exercise price of $6.82.
• The transaction was pre-planned under a Rule 10b5-1 trading plan, indicating a structured approach to managing equity compensation rather than a reaction to recent company performance.

Negatives

• The sale of shares by a key executive, even if pre-planned, slightly reduces their direct ownership in the company.

Risks

• While the transaction was pre-planned, any insider selling, regardless of reason, can sometimes be misinterpreted by the market as a lack of confidence, though this is mitigated by the 10b5-1 plan disclosure.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitive landscape for Hims & Hers Health, Inc.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale of a small number of shares by a CCO is a routine event and is unlikely to have a significant impact on shareholder sentiment or the company's stock price, especially given the 10b5-1 plan.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 reports a routine, pre-planned insider transaction (exercise and sale of options) by a Chief Commercial Officer. While the sale generates proceeds for the insider, it does not provide new fundamental information about the company's performance or future prospects to warrant a change in investment recommendation based solely on this filing. The transaction is a small percentage of the officer's holdings and was executed under a 10b5-1 plan, suggesting it is not based on new material non-public information.

Keywords

Hims & Hers Health, HIMS, Michael Chi, Form 4, Insider Trading, Stock Options, Equity Sale, 10b5-1 Plan, Chief Commercial Officer